Skip to main content Back to Top
Advertisement

4/30/2020

Buspirone Tablets

Products Affected - Description

    • Buspirone tablet, Apnar, 15 mg, bottle, 60 count, NDC 24689-0921-06

Reason for the Shortage

    • Accord has buspirone tablets available.
    • Apnar did not provide a reason for the shortage.
    • Mylan Has buspirone tablets available.
    • Par has buspirone tablets available.
    • Teva has buspirone tablets available.
    • Zydus has buspirone tablets available.

Available Products

    • Buspirone tablet, Accord, 10 mg, bottle, 100 count, NDC 16729-0202-01
    • Buspirone tablet, Accord, 10 mg, bottle, 500 count, NDC 16729-0202-16
    • Buspirone tablet, Accord, 15 mg, bottle, 60 count, NDC 16729-0203-12
    • Buspirone tablet, Accord, 15 mg, bottle, 100 count, NDC 16729-0203-01
    • Buspirone tablet, Accord, 30 mg, bottle, 60 count, NDC 16729-0289-12
    • Buspirone tablet, Accord, 5 mg, bottle, 100 count, NDC 16729-0200-01
    • Buspirone tablet, Accord, 5 mg, bottle, 500 count, NDC 16729-0200-16
    • Buspirone tablet, Apnar, 10 mg, bottle, 100 count, NDC 24689-0907-01
    • Buspirone tablet, Apnar, 10 mg, bottle, 500 count, NDC 24689-0907-05
    • Buspirone tablet, Apnar, 15 mg, bottle, 100 count, NDC 24689-0921-01
    • Buspirone tablet, Apnar, 15 mg, bottle, 500 count, NDC 24689-0921-05
    • Buspirone tablet, Apnar, 30 mg, bottle, 60 count, NDC 24689-0933-06
    • Buspirone tablet, Apnar, 5 mg, bottle, 100 count, NDC 24689-0781-01
    • Buspirone tablet, Apnar, 5 mg, bottle, 500 count, NDC 24689-0781-05
    • Buspirone tablet, Apnar, 7.5 mg, bottle, 100 count, NDC 24689-0785-01
    • Buspirone tablet, Mylan, 10 mg, bottle, 100 count, NDC 00378-1150-01
    • Buspirone tablet, Mylan, 10 mg, bottle, 500 count, NDC 00378-1150-05
    • Buspirone tablet, Mylan, 15 mg, bottle, 60 count, NDC 00378-1165-91
    • Buspirone tablet, Mylan, 15 mg, bottle, 180 count, NDC 00378-1165-80
    • Buspirone tablet, Mylan, 15 mg, bottle, 500 count, NDC 00378-1165-05
    • Buspirone tablet, Mylan, 30 mg, bottle, 60 count, NDC 00378-1175-91
    • Buspirone tablet, Mylan, 5 mg, bottle, 100 count, NDC 00378-1140-01
    • Buspirone tablet, Mylan, 5 mg, bottle, 500 count, NDC 00378-1140-05
    • Buspirone tablet, Mylan Institutional, 10 mg, unit-dose blister pack, 100 count, NDC 51079-0986-20
    • Buspirone tablet, Mylan Institutional, 15 mg, unit-dose blister pack, 100 count, NDC 51079-0960-20
    • Buspirone tablet, Mylan Institutional, 30 mg, unit-dose blister pack, 100 count, NDC 51079-0994-20
    • Buspirone tablet, Mylan Institutional, 5 mg, unit-dose blister pack, 100 count, NDC 51079-0985-20
    • Buspirone tablet, Par Pharmaceuticals, 7.5 mg, bottle, 100 count, NDC 49884-0725-01
    • Buspirone tablet, Par Pharmaceuticals, 7.5 mg, bottle, 500 count, NDC 49884-0725-05
    • Buspirone tablet, Teva, 10 mg, bottle, 100 count, NDC 00093-0054-01
    • Buspirone tablet, Teva, 10 mg, bottle, 500 count, NDC 00093-0054-05
    • Buspirone tablet, Teva, 15 mg, bottle, 100 count, NDC 00093-1003-01
    • Buspirone tablet, Teva, 15 mg, bottle, 500 count, NDC 00093-1003-05
    • Buspirone tablet, Teva, 30 mg, bottle, 60 count, NDC 00093-5200-06
    • Buspirone tablet, Teva, 30 mg, bottle, 500 count, NDC 00093-5200-05
    • Buspirone tablet, Teva, 5 mg, bottle, 100 count, NDC 00093-0053-01
    • Buspirone tablet, Teva, 5 mg, bottle, 500 count, NDC 00093-0053-05
    • Buspirone tablet, Zydus, 10 mg, bottle, 100 count, NDC 68382-0181-01
    • Buspirone tablet, Zydus, 10 mg, bottle, 500 count, NDC 68382-0181-05
    • Buspirone tablet, Zydus, 15 mg, bottle, 100 count, NDC 68382-0182-01
    • Buspirone tablet, Zydus, 15 mg, bottle, 500 count, NDC 68382-0182-05
    • Buspirone tablet, Zydus, 30 mg, bottle, 60 count, NDC 68382-0183-14
    • Buspirone tablet, Zydus, 30 mg, bottle, 500 count, NDC 68382-0183-05
    • Buspirone tablet, Zydus, 5 mg, bottle, 100 count, NDC 68382-0180-01
    • Buspirone tablet, Zydus, 5 mg, bottle, 500 count, NDC 68382-0180-05

Estimated Resupply Dates

    • Apnar has buspirone 15 mg tablets in 60 count bottles on back order and the company estimates a release date of mid-2020.

Updated

Updated April 30, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.